Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Ariana Resources (AAU) by Hot Stock Rockets in ShareProphets
- Avoid Ten Lifestyle Group (TENG) by Steve Moore in ShareProphets
- Avoid Biome Technologies (BIOM) by Steve Moore in ShareProphets
- Buy Aviva (AV.) by Harvey Jones in The Motley Fool
- Buy CMC Markets (CMCX) by Harvey Jones in The Motley Fool
- Buy ITV (ITV) by Simon Watkins in The Motley Fool
- Buy Legal & General Group (LGEN) by Simon Watkins in The Motley Fool
- Hold Vodafone Group (VOD) by DZ Bank
- Buy Premier Foods (PFD) by Jefferies
- Buy Intermediate Capital Group (ICG) by Deutsche Bank
- Overweight WH Smith (SMWH) by JP Morgan
- Outperform TT Electronics (TTG) by RBC Capital
- Buy International Consolidated Airlines Group SA (CDI) (IAG) by Goldman Sachs
- Neutral Dr. Martens (DOCS) by Goldman Sachs
- Buy Intermediate Capital Group (ICG) by Goldman Sachs
- Neutral Vistry Group (VTY) by JP Morgan
- Buy Babcock International Group (BAB) by Jefferies
- Buy Convatec Group (CTEC) by Jefferies
- Buy Altona Rare Earths (REE) by Hot Stock Rockets in ShareProphets
- Avoid Marks Electrical Group (MRK) by Steve Moore in ShareProphets
Oncimmune Holdings (ONC) Share Price
Health Care Sector
NOTE: This is based on 7 open tips for Oncimmune Holdings (ONC)
| Latest Bid : 15.20p | Latest Ask : 15.90p |
| High Today : 15.67p | Low Today : 15.21p |
| This Years High : 29.10p | This Years Low : 9.57p |
| Volume : 66,460 | MKT Cap : £17.15M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Oncimmune Holdings (ONC) Overview
We are leaders in immune biomarkers; our vision is to enable personalised, data-driven clinical decisions across the cancer care continuum. Using our unique expertise and proprietary technology we aim to transform the way disease is diagnosed and treated around the world. We know that detecting the disease early can improve the ability to treat cancer and enhance chances of survival.Oncimmune Holdings (ONC) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Risky Buy | Kirsteen Mackay | Premium Only | 2020-10-13 18:00:00 13/10/2020 | -91.48% |
| Corporate | FinnCap | Premium Only | 2020-03-18 08:55:00 18/03/2020 | – |
| Corporate | FinnCap | Premium Only | 2020-03-04 11:00:00 04/03/2020 | – |
| Corporate | FinnCap | Premium Only | 2020-02-12 09:50:00 12/02/2020 | – |
| Corporate | FinnCap | Premium Only | 2019-11-22 10:25:00 22/11/2019 | – |
Oncimmune Holdings (ONC) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 15.20p | Latest Ask : 15.90p |
| High Today : 15.67p | Low Today : 15.21p |
| This Years High : 29.10p | This Years Low : 9.57p |
| Volume : 66,460 | MKT Cap : £17.15M |
Oncimmune Holdings Overview
We are leaders in immune biomarkers; our vision is to enable personalised, data-driven clinical decisions across the cancer care continuum. Using our unique expertise and proprietary technology we aim to transform the way disease is diagnosed and treated around the world. We know that detecting the disease early can improve the ability to treat cancer and enhance chances of survival.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Oncimmune Holdings Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Risky Buy | Kirsteen Mackay | Premium Only | 2020-10-13 18:00:00 13/10/2020 | -91.48% |
| Corporate | FinnCap | Premium Only | 2020-03-18 08:55:00 18/03/2020 | – |
| Corporate | FinnCap | Premium Only | 2020-03-04 11:00:00 04/03/2020 | – |
| Corporate | FinnCap | Premium Only | 2020-02-12 09:50:00 12/02/2020 | – |
| Corporate | FinnCap | Premium Only | 2019-11-22 10:25:00 22/11/2019 | – |